DSM and Crucell Sign Agreement with Bioceros to Serve as Pre-Approved Cell Line Generation Partner of PER.C6 Cell Line Proteins
11-Feb-2009
- Netherlands
DSM Biologics and Crucell N.V. announced that they have entered into an agreement with Bioceros B.V. to join their Vendor Network. Under the terms of the agreement, Bioceros will be a pre-approved cell line generation partner for licensees of the PER.C6® cell line located in the European Union.
Karen King, president of DSM Biologics notes, "The growing number of PER.C6® licensees requires that we expand the possibilities for our licensees to obtain services like cell line generation. We are confident that Bioceros' excellent experience and service level will provide our European licensees additional options to move their PER.C6® programs forward successfully."
Other terms of the agreement were not disclosed.
Other news from the department business & finance
